zgnx|20191231
The centralized procedure provides for the grant of a single marketing authorization for a medicinal product by the EC on the basis of a positive opinion by the ...
Zogenix, Inc. (“Zogenix,” “we,” “our” and “us”) has one class of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended ...
UCB would acquire Zogenix, Inc., a global biopharmaceutical company commercializing and developing therapies for rare diseases.
UCB Completes Acquisition of Zogenix, Inc.
Broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy ...
Zogenix does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
UCB Completes Acquisition of Zogenix, Inc. - PR Newswire
PRNewswire/ -- UCB (Euronext: UCB) today announced the successful completion of the previously announced transaction to acquire Zogenix ...
Zogenix Stock Price Today | NASDAQ: ZGNX Live - Investing.com
What Is the Zogenix Inc Stock Price Today? The Zogenix Inc stock price today is 26.68. What Is the Stock Symbol for Zogenix Inc? The stock ticker symbol for ...
ZGNX - Zogenix Stock Price - Barchart.com
Zogenix Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
Zogenix Inc (ZGNX) $26.68 (NASDAQ) Share Price Today
Get Zogenix Inc (ZGNX) share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding, and financial ...
UCB to buy Zogenix for nearly $2B in 'first step' for M&A in 2022
UCB to buy Zogenix for nearly $2B in 'first step' for M&A in 2022 ... Belgium's UCB on Wednesday said it has agreed to acquire Zogenix for as much ...
How did UCB close its $1.9B deal to buy Zogenix and its key ...
A Securities and Exchange Commission filing revealed UCB emerged over two other unnamed pharma companies in its acquisition of Zogenix and its potential ...
UCB to acquire Zogenix - PR Newswire
UCB would acquire Zogenix, Inc., a global biopharmaceutical company commercializing and developing therapies for rare diseases.
About UCB in the United States
UCB, a global biopharmaceutical company, has several locations. Global headquarters are in Brussels, Belgium, with U.S. headquarters in Atlanta, Georgia.
02009R0428-20191231 - EN - EUR-Lex - European Union
Consolidated text: Rådets förordning (EG) nr 428/2009 av den 5 maj 2009 om upprättande av en gemenskapsordning för kontroll av export, överföring, förmedling ...
Zogenix, Inc. (ZGNX) 10K Annual Reports & 10Q SEC Filings
The Company recorded $81.7 million in revenue for the year ended December 31, 2021. This included total net product sales of FINTEPLA of $74.7 million, in ...
Zogenix | ZGNX Stock Price, Company Overview & News - Forbes
Zogenix · More on Forbes · Top Stocks To Short Today As Markets Set To Sluggishly End November · Exxon Mobil Top Short As Oil Drops · How The Parts Add Up: The ...
ZGNX - Stock Price, Institutional Ownership, Shareholders (NASDAQ)
Institutional Ownership and Shareholders. Zogenix Inc (US:ZGNX) has 1 institutional owners and shareholders that have filed 13D/G or 13F forms with the ...
Zogenix (ZGNX) Stock Surges on Acquisition Offer From UCB
Zogenix's ZGNX shares surged 65.7% on Wednesday, after it announced that it has signed a definitive agreement with Belgium-based ...
Zogenix, Inc. – Cash Settlement/Acceleration of Expirations Option ...
On March 4, 2022, Zinc Merger Sub, Inc., an indirect wholly owned subsidiary of UCB S.A., completed its tender offer for Zogenix, Inc. (ZGNX).